Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Au-Ag-Cu2O Nanogel PTT for Severe Drug-resistant Microbial Keratitis
NCT05268718Phase 1Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Modality
- Hydrogel Systems, Nanoparticles
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of gold + silver + copper(I) oxide nanogel in fungal keratitis (FK), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Anterior segment photography at 1 month and Confocal microscopy at 1 month. Status: unknown.
02
Drugs
gold + silver + copper(I) oxide nanogel
03
Conditions
fungal keratitis (FK)
Beyond the preview
Go deeper on NCT05268718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05268718.